Sandip Das is currently serving as the Business Unit Head for Oncology & Specialty at Eisai Pharmaceuticals India, overseeing operations in India, Sri Lanka, and Bangladesh. Prior to this role, Sandip held managerial positions at Lupin India, Boehringer Ingelheim, GSK, AstraZeneca, and Dr. Reddy's Laboratories, gaining extensive experience in sales and marketing in the pharmaceutical industry. Sandip has a strong educational background, including a Post Graduate Certificate in Senior Leadership from XLRI Jamshedpur and various courses from Harvard Business School Online.
Previous companies
January, 2023 - present